Sanghoon Lee

Sanghoon Lee is a highly skilled professional with a strong background in investor relations and regulatory affairs. Currently serving as a Senior Investor Relation Specialist and Senior Regulatory Affairs Specialist at 삼성 바이오로직스 since June 2022, Sanghoon has extensive experience in the pharmaceutical industry, previously working as a Global Regulatory Affairs Specialist at Daewoong Pharmaceuticals from January 2017 to June 2022, where responsibilities included managing overseas new drug approvals and existing approvals. Sanghoon holds a bachelor's degree in Business Administration from 성균관대학교 (Sungkyunkwan University) and is currently pursuing further education at the University of Otago.